These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


188 related items for PubMed ID: 334673

  • 1. [Azlocillin and mezlocillin: two new semisynthetic acylureido-penicillins (author's transl)].
    Lode H, Niestrath U, Koeppe P, Langmaack H.
    Infection; 1977; 5(3):163-9. PubMed ID: 334673
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pediatric pharmacology of azlocilin (author's transl)].
    Sitka U, Weingärtner L, Patsch R, Richter I.
    Padiatr Padol; 1979; 14(4):429-40. PubMed ID: 530731
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [In vitro activity of mezlocillin, azlocillin and carbenicillin against bacteroidaceae with particular reference to bacteroides fragilis (author's transl)].
    Werner H, Krassemann C, Ungerechts J, Schmitz HJ.
    Infection; 1977; 5(1):17-21. PubMed ID: 585371
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
    Gundert-Remy U, Weber E.
    Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
    [Abstract] [Full Text] [Related]

  • 13. Microbiology, pharmacology, and clinical use of mezlocillin sodium.
    McCloskey RV, LeFrock JL, Smith BR, Aronoff GR.
    Pharmacotherapy; 1982; 2(6):300-12. PubMed ID: 6220263
    [Abstract] [Full Text] [Related]

  • 14. [Pharmakokinetic and clinical studies with azlocillin in paediatrics (author's transl)].
    Weingärtner L, Sitka U, Patsch R, Richter I, Thiemann HH.
    Klin Padiatr; 1980 Sep; 192(5):419-29. PubMed ID: 7192337
    [Abstract] [Full Text] [Related]

  • 15. [In vitro susceptibility of gram-negative bacteria isolated from urinary tract infections to acylureidopenicillins].
    Cerikcioğlu N, Ustaçelebi S, Günalp A.
    Mikrobiyol Bul; 1986 Jul; 20(3):139-44. PubMed ID: 3561279
    [Abstract] [Full Text] [Related]

  • 16. Azlocillin, mezlocillin, and piperacillin: new broad-spectrum penicillins.
    Eliopoulos GM, Moellering RC.
    Ann Intern Med; 1982 Nov; 97(5):755-60. PubMed ID: 6215872
    [Abstract] [Full Text] [Related]

  • 17. [Antibacterial activity of mezlocillin and azlocillin/A survey (author's transl)].
    Knothe H.
    Arzneimittelforschung; 1979 Nov; 29(12a):1916-20. PubMed ID: 120745
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [In vitro effect of acylureido penicillins and mezlocillin on anaerobic sporeless gram-negative rods of genus Bacteroides].
    Höhne C.
    Infection; 1982 Nov; 10 Suppl 3():S238-43. PubMed ID: 6218120
    [Abstract] [Full Text] [Related]

  • 20. Comparative study of the binding of acylureidopenicillins and carbenicillin to human serum proteins.
    Rosenkranz H, Förster D.
    Infection; 1979 Nov; 7(3):102-8. PubMed ID: 478650
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.